GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Plcb1 | decreases expression | EXP | | 6480464 | CTD | bisphenol A results in decreased expression of PLCB1 mRNA | PMID:25181051 PMID:30816183 PMID:34947998 | Plcb1 | increases expression | EXP | | 6480464 | CTD | bisphenol A results in increased expression of PLCB1 mRNA | PMID:32145629 | Plcb1 | increases methylation | EXP | | 6480464 | CTD | bisphenol A results in increased methylation of PLCB1 gene | PMID:28505145 | Plcb1 | multiple interactions | EXP | | 6480464 | CTD | [bisphenol A co-treated with Testosterone] results in increased expression of PLCB1 mRNA | PMID:26496021 | Plcb1 | decreases expression | ISO | Plcb1 (Mus musculus) | 6480464 | CTD | bisphenol A results in decreased expression of PLCB1 mRNA | PMID:26063408 | Plcb1 | decreases methylation | ISO | PLCB1 (Homo sapiens) | 6480464 | CTD | bisphenol A results in decreased methylation of PLCB1 gene | PMID:31601247 | Plcb1 | increases expression | ISO | PLCB1 (Homo sapiens) | 6480464 | CTD | bisphenol A results in increased expression of PLCB1 mRNA | PMID:36828454 | Plcb1 | multiple interactions | ISO | PLCB1 (Homo sapiens) | 6480464 | CTD | [bisphenol A co-treated with Fulvestrant] affects the methylation of PLCB1 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PLCB1 mRNA | PMID:28628672 PMID:31601247 | |
Go Back to source page | Continue to Ontology report |